Betül Sarı Kalın
Research Subjects
Betül Sarı Kalın has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Aktaş
SİVAS CUMHURİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
1 shared publication - Ali Sahin
Department of Rheumatology, Sivas Cumhuriyet University School of Medicine, Sivas, Turkey.
1 shared publication - Mustafa Asım Gedikli
Department of İnternal Medicine, Faculty of Medicine, Sivas Cumhuriyet University, Sivas, Turkey
1 shared publication - Neşe Çabuk Çelik
Department of Rheumatology, Sincan Training and Research Hospital, Ankara, Turkey
1 shared publication - Rumeysa Yilmaz Goc
Department of Histology and Embryology, Sivas Cumhuriyet University Faculty of Medicine, Sivas, Türkiye
1 shared publication - Serpil Albayrak
Department of Pediatric Endocrinology, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye
1 shared publication
Latest Publications
- Open Access
- 25 June 2026
- Published by SAGE Publications in Indian Journal of Rheumatology
Genotype-phenotype Interactions and Autoimmune Comorbidities in Adult Familial Mediterranean Fever: A Retrospective Cohort Study of 786 Patients
Background: Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disorder characterised by recurrent febrile attacks and serosal inflammation. Although Mediterranean fever gene (MEFV) gene mutations are central to disease pathogenesis, considerable phenotypic heterogeneity exists and the contribution of autoimmune comorbidities to disease expression remains insufficiently characterised in adult populations. Objective: This study aimed to evaluate genotype-phenotype associations and to assess the frequency and clinical impact of autoimmune comorbidities in a large cohort of adult patients with FMF. Methods: We retrospectively analysed 786 adult FMF patients diagnosed according to the Tel-Hashomer criteria. Demographic characteristics, MEFV mutation profiles, clinical manifestations during attacks, acute-phase reactants, treatment regimens and response to colchicine were systematically recorded. Genetic analyses were performed using sequencing-based methods. Statistical analyses were conducted using Statistical Package for the Social Sciences software. Results: Arthralgia was the most frequent clinical manifestation (89.8%), followed by abdominal pain and myalgia. Homozygous MEFV mutations, particularly M694V homozygosity, were significantly associated with increased disease severity, higher attack frequency and colchicine resistance. Autoimmune comorbidities were identified in 30.4% of patients, with ankylosing spondylitis being the most common (19.8%). Patients with homozygous M694V mutations exhibited higher rates of colchicine resistance ( P = .021) and required interleukin-1 inhibitors more frequently ( P = .003). Conclusion: FMF exhibits marked clinical heterogeneity influenced by both genetic background and coexisting autoimmune conditions. Homozygous M694V mutations are associated with severe disease and treatment resistance. Routine evaluation for autoimmune comorbidities may facilitate individualised treatment strategies in adult FMF patients.
- 25 June 2026
- Published by SAGE Publications in Indian Journal of Rheumatology
Open AccessGenotype-phenotype Interactions and Autoimmune Comorbidities in Adult Familial Mediterranean Fever: A Retrospective Cohort Study of 786 Patients
Background: Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disorder characterised by recurrent febrile attacks and serosal inflammation. Although Mediterranean fever gene (MEFV) gene mutations are central to disease pathogenesis, considerable phenotypic heterogeneity exists and the contribution of autoimmune comorbidities to disease expression remains insufficiently characterised in adult populations. Objective: This study aimed to evaluate genotype-phenotype associations and to assess the frequency and clinical impact of autoimmune comorbidities in a large cohort of adult patients with FMF. Methods: We retrospectively analysed 786 adult FMF patients diagnosed according to the Tel-Hashomer criteria. Demographic characteristics, MEFV mutation profiles, clinical manifestations during attacks, acute-phase reactants, treatment regimens and response to colchicine were systematically recorded. Genetic analyses were performed using sequencing-based methods. Statistical analyses were conducted using Statistical Package for the Social Sciences software. Results: Arthralgia was the most frequent clinical manifestation (89.8%), followed by abdominal pain and myalgia. Homozygous MEFV mutations, particularly M694V homozygosity, were significantly associated with increased disease severity, higher attack frequency and colchicine resistance. Autoimmune comorbidities were identified in 30.4% of patients, with ankylosing spondylitis being the most common (19.8%). Patients with homozygous M694V mutations exhibited higher rates of colchicine resistance ( P = .021) and required interleukin-1 inhibitors more frequently ( P = .003). Conclusion: FMF exhibits marked clinical heterogeneity influenced by both genetic background and coexisting autoimmune conditions. Homozygous M694V mutations are associated with severe disease and treatment resistance. Routine evaluation for autoimmune comorbidities may facilitate individualised treatment strategies in adult FMF patients.
- Open Access
- 14 April 2022
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 7 (1) , 27-31
Relationship Between HbA1c Level and Triglyceride/HDL Cholesterol Ratio and Triglyceride Glucose Index in Diabetes Patients
- 14 April 2022
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 7 (1) , 27-31
Open AccessRelationship Between HbA1c Level and Triglyceride/HDL Cholesterol Ratio and Triglyceride Glucose Index in Diabetes Patients